Gene Expression In Pregnancies Complicated by Preeclampsia
NCT00919360 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 125
Last updated 2015-10-21
Summary
The purpose of this study is to figure out some of the differences in bodily function between women who have preeclampsia and those who do not.
* This may eventually lead to an understanding of its cause. At this time, there is no known way to prevent preeclampsia, and the cause is not known.
* The only treatment is delivery of the baby, even if it is premature, in order to decrease the risk to the mother.
Conditions
Interventions
- PROCEDURE
-
collection of maternal blood specimen prior to delivery
approximately 5 cc. of maternal blood will be drawn prior to delivery
- PROCEDURE
-
collection of placental cord blood after delivery
approximately 5 cc. of fetal cord blood from the umbilical cord blood vessel will be collected after cord is clamped
- PROCEDURE
-
collection of placental tissue
within 10 minutes of delivery, the placenta will be radially transected, and a full-thickness slice from the central region removed using sterile technique by scalpel.This will be placed into a pre-prepared container of RNA preservation medium.
- PROCEDURE
-
collection of strip of decidua from uterine lining from cesarean section deliveries
A strip of decidua will be removed from the upper lip of uterine incision by the surgeon and placed in RNA preservation medium.
Sponsors & Collaborators
-
University of Rochester
lead OTHER
Principal Investigators
-
Eva Pressman, MD · University of Rochester
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-06-30
- Primary Completion
- 2015-07-31
- Completion
- 2015-07-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography
NCT06099275 ·Status: SUSPENDED
-
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
NCT03767803 ·Status: UNKNOWN
-
Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes
NCT06067685 ·Status: TERMINATED
-
First-trimester Prediction of Preeclampsia
NCT02189148 ·Status: COMPLETED
-
Family Study on Preeclampsia
NCT00344162 ·Status: COMPLETED
-
Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy
NCT05186779 ·Status: TERMINATED
-
A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk
NCT00572793 ·Status: COMPLETED
-
Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and Vascular Development
NCT02639676 ·Status: COMPLETED
-
The Role of Cytokines in Apparently Normal Pregnancies
NCT01098214 ·Status: WITHDRAWN
-
Placental Expression of EG-VEGF and Its PROKR1 and PROKR2 Receptors in Preeclampsia Patients.
NCT04846686 ·Status: COMPLETED
-
Epigenomic Dysregulation in Preeclampsia-Associated Chronic Hypertension
NCT01682304 ·Status: COMPLETED
-
Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia
NCT04204018 ·Status: COMPLETED ·Phase: NA
-
PREPARE, Prematurity Reduction by Pre-eclampsia Care
NCT03073317 ·Status: COMPLETED ·Phase: NA
-
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
NCT02808494 ·Status: COMPLETED
-
Different Regulation of Immune Cells in Patients With Preeclampsia
NCT02691364 ·Status: UNKNOWN
-
A Modernized Approach to Prenatal Care in Low Risk Women
NCT01606774 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia
NCT01566630 ·Status: TERMINATED ·Phase: PHASE2
-
Causal Relationship Between Plasma VEGF Family Proteins and Placenta Previa: A Two-Sample Mendelian Randomization Study
NCT06620068 ·Status: NOT_YET_RECRUITING
-
First Trimester Prediction of Preeclampsia and Fetal Growth Restriction
NCT02379494 ·Status: COMPLETED
-
Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
NCT06157580 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969 ·Status: UNKNOWN
-
Progesterone for First Trimester Vaginal Bleeding
NCT01501890 ·Status: WITHDRAWN ·Phase: NA
-
Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion
NCT04232189 ·Status: TERMINATED
-
LMWH to Prevent Preeclampsia and Fetal Growth Restriction
NCT00260520 ·Status: TERMINATED
-
Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia.
NCT06122220 ·Status: RECRUITING ·Phase: NA